Filed 3.4y ago· Jan 20, 2023
39 days to disclose
Christopher L. Jacobs
RHouseNew York-27
↑bought
Healthpeak Properties
DOC
$1K-$15K
−37.5% vs S&P 500
Trade dateDec 12, 2022
Shares of Beneficial Interest
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.




































































































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Healthpeak Properties DOC Shares of Beneficial Interest | Dec 12, 2022 39 days to disclose | Bad buy·−$1.8K-22.5% −37.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | First Horizon FHN | Dec 12, 2022 39 days to disclose | Good buy·+$186+2.3% −46.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Gevo GEVO | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Anavex Life Sciences AVXL | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Kalvista Pharmaceuticals KALV | Dec 12, 2022 39 days to disclose | Good buy·+$28.2K+352.1% +262.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Biolife Solutions BLFS | Dec 12, 2022 39 days to disclose | Good buy·+$824+10.3% −79.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Crescent Energy CRGY | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Coterra Energy CTRA | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Cogent Biosciences COGT | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Claros Mortgage Trust CMTG | Dec 12, 2022 39 days to disclose | Bad buy·−$6.8K-84.9% −134.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Chevron CVX | Dec 12, 2022 39 days to disclose | Good buy·+$877+11.0% −27.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Chord Energy CHRD | Dec 12, 2022 39 days to disclose | Good buy·+$413+5.2% −33.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Borr Drilling Ltd. BORR | Dec 12, 2022 39 days to disclose | Good buy·+$3.3K+41.4% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Archrock AROC | Dec 12, 2022 39 days to disclose | Good buy·+$29.4K+367.7% +277.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Bank of America BAC | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Krystal Biotech KRYS | Dec 12, 2022 39 days to disclose | Good buy·+$24.2K+302.8% +293.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Tesla TSLA | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Relmada Therapeutics RLMD | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Uranium Energy UEC | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Tellurian Inc TELL Tellurian | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | SpringWorks Therapeutics SWTX common stock | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Pioneer Natural PXD | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | National Energy Services Reunited NESR Corp. - Ordinary Shares | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Permian Resources PR A | Dec 12, 2022 39 days to disclose | Good buy·+$10.8K+134.6% +96.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | International Seaways INSW.V Stock When Issued | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Helix Energy Solutions HLX | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | ExxonMobil XOM Exxon Mobil | Dec 12, 2022 39 days to disclose | Good buy·+$3.5K+43.3% +4.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Inotiv NOTV | Dec 12, 2022 39 days to disclose | Bad buy·−$7.4K-92.9% −182.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Home Depot HD | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Helmerich & Payne HP | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Civitas Resources CIVI | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Cassava Sciences, Inc SAVA Cassava Sciences | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Brigham Minerals MNRL | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Berkshire Hathaway BRK.B | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Expro Group Holdings N.v. XPRO | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Athira Pharma, Inc ATHA Athira Pharma | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Meta Platforms META Meta Platforms, Inc. - Class A | Dec 12, 2022 39 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Netstreit NTST | Dec 12, 2022 39 days to disclose | Good buy·+$531+6.6% −83.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Kura Oncology KURA | Dec 6, 2022 45 days to disclose | Bad buy·−$12.3K-37.8% −130.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Uranium Energy UEC | Nov 8, 2022 34 days to disclose | Good buy·+$23.5K+294.3% +268.0% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Akero Therapeutics AKRO Akero Therapeutics | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Athira Pharma, Inc ATHA Athira Pharma | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Atreca, Inc. - BCEL | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Berkshire Hathaway BRK.A Berkshire Hathaway | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Cassava Sciences, Inc SAVA Cassava Sciences | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Enochian Biosciences ENOB Enochian Biosciences | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | H HSAC Corporation | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Chevron CVX | Nov 8, 2022 34 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | ExxonMobil XOM Exxon Mobil | Nov 8, 2022 34 days to disclose | Good buy·+$2.7K+33.4% +7.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Shoulder Innovations SI Silvergate Capital Corporation Class A | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Tellurian, Inc TLRN Tellurian, Inc, | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Healthpeak Properties DOC Shares of Beneficial Interest | Nov 8, 2022 34 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Plug Power PLUG | Nov 8, 2022 34 days to disclose | Bad buy·−$6.2K-77.7% −110.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | JPMorgan Chase JPM JP Morgan Chase & | Nov 8, 2022 34 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Kodiak Sciences KOD | Nov 8, 2022 34 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | AGNC Investment AGNC | Nov 8, 2022 34 days to disclose | Good buy·+$2.1K+26.1% +4.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Bank of America BAC | Nov 8, 2022 34 days to disclose | Good buy·+$3.7K+46.0% −5.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Flex Lng Ltd. FLNG | Nov 8, 2022 34 days to disclose | Bad buy·−$628-7.8% −34.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Helix Energy Solutions HLX | Nov 8, 2022 34 days to disclose | Good buy·+$3.5K+43.8% +17.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Gevo GEVO | Nov 8, 2022 34 days to disclose | Bad buy·−$646-8.1% −106.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Johnson & Johnson JNJ | Nov 8, 2022 34 days to disclose | Good buy·+$2.5K+31.3% +16.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Home Depot HD | Nov 8, 2022 34 days to disclose | Good buy·+$517+6.5% −65.7% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Sabra Health Care Reit SBRA | Nov 8, 2022 34 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Relmada Therapeutics RLMD | Nov 8, 2022 34 days to disclose | Good buy·+$2.5K+31.0% +16.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | JPMorgan Chase JPM JP Morgan Chase & | Oct 18, 2022 29 days to disclose | Good buy·+$12.9K+161.6% +100.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Anavex Life Sciences AVXL | Oct 12, 2022 35 days to disclose | Bad buy·−$5.5K-68.4% −180.7% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | IVERIC bio, Inc ISEE IVERIC bio | Oct 12, 2022 35 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Civitas Resources CIVI | Oct 12, 2022 35 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Bank of America BAC | Oct 12, 2022 35 days to disclose | Good buy·+$6.5K+81.4% +9.1% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Pfizer PFE | Oct 12, 2022 35 days to disclose | Bad buy·−$3.1K-38.9% −63.6% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Expro Group Holdings N.v. XPRO | Oct 12, 2022 35 days to disclose | Good buy·+$665+8.3% −104.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Innovative Industrial Properties IIPR | Oct 12, 2022 35 days to disclose | Bad buy·−$3K-38.0% −68.6% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Chevron CVX | Oct 12, 2022 35 days to disclose | Good buy·+$1.6K+19.5% −27.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | ExxonMobil XOM Exxon Mobil | Oct 12, 2022 35 days to disclose | Good buy·+$4.4K+54.5% +7.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Amylyx Pharmaceuticals AMLX | Oct 12, 2022 35 days to disclose | Bad buy·−$4.2K-52.2% −164.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | AGNC Investment AGNC | Oct 12, 2022 35 days to disclose | Good buy·+$2.8K+34.9% +4.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Tellurian Inc TELL Tellurian | Oct 7, 2022 40 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 16, 2022 3.6y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Broadmark Realty BRMK | Oct 7, 2022 40 days to disclose | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Athira Pharma, Inc ATHA Athira Pharma | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Healthpeak Properties DOC Shares of Beneficial Interest | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Scorpio Tankers STNG | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Innovative Industrial Properties IIPR | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | First Horizon FHN | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Inotiv NOTV | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Bad buy·−$7.8K-97.6% −195.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Home Depot HD | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Kite Realty Group Trust KRG | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Good buy·+$4.3K+53.4% +44.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Associated Banc-Corp ASBC | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Cassava Sciences, Inc SAVA Cassava Sciences | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Centennial Resource Development CDEV Inc. - Class A | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Civitas Resources CIVI | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Earthstone Energy ESTE | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Enochian Biosciences ENOB Enochian Biosciences | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Crescent Energy CRGY | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Bad buy·−$463-5.8% −73.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Genco Shipping & Trading GNKOQ | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | IVERIC bio, Inc ISEE IVERIC bio | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | ExxonMobil XOM Exxon Mobil | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Antero Resources AR | Jul 18, 2022 53 days to disclose · 8 past 45-day window | Flat·+0.0% | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Shoulder Innovations SI Silvergate Capital Corporation Class A | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↑bought | Tellurian Inc TELL Tellurian | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | ![]() Christopher L. Jacobs RHouseNew York-27 | ↓sold | Vertex Energy, Inc VTNR Vertex Energy | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |